SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-22-017356
Filing Date
2022-06-16
Accepted
2022-06-16 16:12:40
Documents
14
Period of Report
2022-06-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K blcm-20220615.htm   iXBRL 8-K 55774
2 EX-10.1 exhibit101bellicum2019equi.htm EX-10.1 225647
  Complete submission text file 0001628280-22-017356.txt   484136

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20220615.xsd EX-101.SCH 2156
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20220615_def.xml EX-101.DEF 14380
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20220615_lab.xml EX-101.LAB 27854
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20220615_pre.xml EX-101.PRE 14917
8 EXTRACTED XBRL INSTANCE DOCUMENT blcm-20220615_htm.xml XML 10774
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 221020698
SIC: 2834 Pharmaceutical Preparations